M&A Deal Summary

LabCorp Acquires NWT

On January 24, 2008, LabCorp acquired life science company NWT

Acquisition Highlights
  • This is LabCorp’s 7th transaction in the Life Science sector.
  • This is LabCorp’s 11th transaction in the United States.
  • This is LabCorp’s 2nd transaction in Utah.

M&A Deal Summary

Date 2008-01-24
Target NWT
Sector Life Science
Buyer(s) LabCorp
Deal Type Add-on Acquisition

Target

NWT

Salt Lake City, Utah, United States
NWT, Inc. is a SAMHSA certified laboratory. NWT a drugs-of-abuse and adulterant testing.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

LabCorp

Burlington, North Carolina, United States

Category Company
Sector Test/Measurement Equipment
Employees67,000
Revenue 12.2B USD (2023)
DESCRIPTION
LabCorp's corporate headquarters in downtown Burlington, North Carolina.
LabCorp's corporate headquarters in downtown Burlington, North Carolina.

LabCorp of America Holdings is a provider of medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp is based in Burlington, North Carolina.


DEAL STATS #
Overall 11 of 44
Sector (Life Science) 7 of 21
Type (Add-on Acquisition) 11 of 28
State (Utah) 2 of 3
Country (United States) 11 of 42
Year (2008) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-01-24 Tandem Labs

Salt Lake City, Utah, United States

Tandem Labs Inc. is an contract research organization (CRO) providing bioanalytical and immunoanalytical services to the pharmaceutical, biopharmaceutical and biotechnology industries to support their clinical drug development programs.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-06-24 Monogram

South San Francisco, California, United States

Monogram, Inc. is a diagnostic lab specializing in HIV resistance testing. Monogram is a provider of companion diagnostics molecular diagnostic products that help guide and target appropriate treatments.

Buy $155M